Time |
Event |
Presenter |
Room |
7:00-8:00am |
ICRN Meeting (by invitation only) |
|
151G |
8:00-8:15am |
Conference Welcome by Chairs |
Jennifer Knox and Lewis Roberts |
251 |
8:15-8:45am |
Foundation Update |
Stacie Lindsey, Cholangiocarcinoma Foundation |
251 |
8:45-9:00am |
Who invited you, Death, into our home? |
Steinunn Olina Thorsteinsdottir |
251 |
Epidemiology and Classification of Cholangiocarcinoma
Session Chair: Jesus Banales, Biodonostia Institute |
9:00-9:15am |
SEER, GLOBOCAN, Global Burden of Disease |
Jill Koshiol, NIH |
251 |
9:15-9:30am |
Cholangiocarcinoma : The Need for Accurate Coding and a Call for Action |
Tushar Patel , Mayo Clinic |
251 |
9:30-9:45am |
Local and Regional US Epidemiology of Cholangiocarcinoma |
Paul Zakas, Komodo Health |
251 |
9:45-10:15am |
Panel Discussion |
|
251 |
10:15-11:00am |
Break |
|
|
10:15-11:15am |
CholangioConnect Meeting (by invitation only) |
|
254A |
Genetic Risk Factors for Cholangiocarcinoma
Session Chair: Steven Gallinger, University of Toronto |
11:00-11:15am |
Germline Genomic Syndromes - Cohorts & PARP Inhibitors |
Tanios Bekaii-Saab, Mayo Clinic |
251 |
11:15-11:30pm |
HRD Targets |
Dan Durocher, The Lunenfeld-Tanenbaum Research Institute |
251 |
11:30-11:45pm |
Metachronous Metastases in BRCA1-Mutant Cholangiocarcinoma Harboring a Novel YWHAZ-BRAF Fusion |
Huat Chye Lim, UCSF |
251 |
11:45-12:00pm |
Panel Discussion |
|
251 |
12:00-2:00pm |
Lunch and Networking |
|
250 |
12:00-2:00pm |
Industry Forum I (by invitation only) |
|
151ABC |
12:00-2:00pm |
EPIC Session I (by invitation only) |
|
151G |
State of the Art: Current Treatment of Cholangiocarcinoma
Session Chair: Vincent Tam, University of Calgary |
2:00-2:15pm |
Surgical Management of Cholangiocarcinoma |
Julie Heimbach, Mayo Clinic |
251 |
2:15-2:30pm |
Adjuvant Management of Cholangiocarcinoma |
Anthony El Khoueiry, University of Southern California |
251 |
2:30-2:45pm |
State of the Art Standards in Management - Advanced Disease |
Lipika Goyal, MGH |
251 |
2:45-3:00pm |
Panel Discussion |
|
251 |
Immunotherapy
Session Chair: Anthony El Khoueiry, USC |
3:00-3:15pm |
Targeting the Immune System in Pre-Clinical Cholangiocarcinoma Models |
Sumera Rizvi, Mayo Clinic |
251 |
3:15-3:30pm |
Overview of Data for Immunotherapy |
Katie Kelley, UCSF |
251 |
3:30-3:45pm |
Panel Discussion |
|
251 |
3:45-4:15pm |
Break |
|
|
Regional and International Collaborations
Session Chair: Juan Valle, University of Manchester |
4:15-4:30pm |
Collaborations in Europe: The European Network |
Jesus Banales, Biodonostia Institute, Spain |
251 |
4:30-4:45pm |
Collaborations in Asia: The TIGER Consortium |
Anuradha Budhu, NIH |
251 |
4:45-5:00pm |
Collaborations in North America |
Laura Goff, Vanderbilt University |
251 |
5:00-5:15pm |
Panel Discussion |
|
251 |
CCF Research Fellowship Reports
Session Chair: Ghassan Abou-Alfa, MSKCC |
5:15-5:25pm |
Role of PlGF/Nrp1 Pathway in Intrahepatic Cholangiocarcinoma Cell Survival, Tumor-associated Fibrosis and Abnormal Vasculature |
Shuichi Aoki, Harvard University |
251 |
5:25-5:35pm |
Developing Organotypic Slice Cultures as a New Model System in Cholangiocarcinoma |
Iris Sze Ue Luk, Fred Hutchinson Cancer Center |
251 |
5:35-5:45pm |
Single-cell Immunogenomic Profiling of Neoantigen-reactive T Cells in Human Cholangiocarcinoma |
Yi-Ping "Irene" Shih, Providence Portland Medical Center |
251 |
5:45-6:00pm |
Caregiver Perspective |
Helen Scott |
251 |
6:00-7:00pm |
Dinner |
|
250 |
7:00-8:30pm |
CCF Strategic Plan Preview for Donors (by invitation only) |
|
254A |
7:00-9:00pm |
Poster Session and Networking |
|
250 |